Literature DB >> 4817079

Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.

P Lund-Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4817079     DOI： 10.1111/j.0954-6820.1974.tb08107.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  15 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

2.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

Review 3.  The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.

Authors:  R Eston; D Connolly
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

4.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

5.  Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group.

Authors:  D B Frewin; P Aldons; L L Wilson; E F O'Sullivan; R N Wyndham; J Karrasch; J Agar; B B Singh; B Jackson; P F Atkins
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man.

Authors:  S B Pearson; D C Banks; J M Patrick
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

9.  Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

10.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.